Jaguar HealthJAGX
13F holders, Q2 2025 (June 30)8holders
1new positions
1sold out
$2.54avg. 13F price*
At the end of Q2 2025, 8 institutions reported holding Jaguar Health Inc. (JAGX) in their 13F filings, unchanged from Q1 2025. 1 opened new positions and 1 sold out. The largest holders were UBS Group AG ($28K), Tower Research Capital LLC (TRC) ($4K) and Royal Bank of Canada ($2K).
- Company
- Jaguar Health Inc.
- CUSIP
- 47010C888
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $4K |
| Exits | 1 | $10 |
All 13F filers, Q1 2025 → Q2 2025: 8,629 shares bought and 2 shares sold, net +8,627 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| UBS Group AG | 0.00% | Add +158.9% | 11,173 | $28K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,591 | $4K |
| Royal Bank of Canada | 0.00% | No change | 702 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Add +900.0% | 200 | $504 |
| Leonteq Securities AG | 0.00% | No change | 188 | $474 |
| Morgan Stanley | 0.00% | No change | 10 | $25 |
| Bank of America Corp. | 0.00% | No change | 4 | $10 |
| BlackRock, Inc. | 0.00% | No change | 4 | $10 |
"% of holder's portfolio" is JAGX's weight in each manager's 13F, not the share of Jaguar Health Inc. the manager owns.